2.760EUR+13.11%Mkt Cap: 48.56M $P/E: 46.331d ago
ABL Diagnostics Société anonyme provides proprietary molecular biology assays and end-to-end solutions to be used for molecular detection by polymerase chain reaction (PCR) and through DNA sequencing in France and intern…
Industry Peers
Health Information Servicesvs Health Information Services
P/E
Pricier
P/B
Pricier
Div Yield
Lower
1M Perf
Higher
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$2.53BUSD
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
—
—
Indicators:|
Key Statistics
Company
Market Cap48.56M $
Enterprise Value49.57M $
Revenue (TTM)8.66M $
Gross Profit7.20M $
Net Income (TTM)1.07M $
Revenue/Share0.5261 USD
Last Price2.760 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees22
CountryFR
SectorHealthcare
IndustryHealth Information Services
ISINFR001400AHX6
Valuation
P/E (Trailing)46.33
P/E (Forward)—
PEG1.94
EV/EBITDA106.47
EV/Revenue5.73
P/S5.61
P/B5.85
EPS (TTM)0.06
EPS (Forward)—
52W Range
2.12018% of range5.750
52W High5.750 EUR
52W Low2.120 EUR
Profitability
Gross Margin95.29%
Oper. Margin8.18%
EBITDA Margin5.38%
Profit Margin14.20%
ROE12.93%
ROA7.62%
Growth
Revenue Growth58.80%
Earnings Growth300.70%
Cash Flow & Leverage
Operating CF1.64M $
CapEx (TTM)861.60K $
FCF Margin13.27%
FCF Yield2.37%
Net Debt1.01M $
Net Debt/EBITDA2.18
Balance Sheet
Debt/Equity0.29
Current Ratio2.41
Quick Ratio2.08
Book Value/Sh0.4750 EUR
Cash/Share0.0820 EUR
Dividends
Fwd Div Rate0.1100 EUR
Trail. Div Rate0.1100 EUR
Div. Yield4.40%
5Y Avg Yield—
Payout Ratio81.43%
Ex-Div DateJul 3, 2026
Pay Date—
Splits
Last Split8:1
Split DateMay 18, 2022
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.16.07M
Float76.97K
Insiders97.25%
Institutions0.00%
Technical
SMA 502.839 (-2.8%)
SMA 2003.339 (-17.3%)
Beta-0.53
S&P 52W Chg20.05%
Avg Vol (30d)19.29K
Avg Vol (10d)11.13K
Technical Indicators
RSI (14)50.7
MACD-0.1287
MACD Signal-0.1366
MACD Hist.+0.0079
BB Upper3.129 EUR
BB Middle2.660 EUR
BB Lower2.191 EUR
BB Width35.24%
ATR (14)0.2402 EUR
Vol Ratio (20d)0.42x